Eli Lilly (NYSE: LLY) has been a terrific investment in recent years. Thanks to significant clinical progress and outstanding ...

New findings presented at the 2025 Alzheimer’s Association International Conference (AAIC) in Toronto spotlighted the long-term potential of two FDA-approved Alzheimer’s treatments for people with ...

Stocks surged Monday, led by tech sector gains, as the market recovered from a steep decline at the end of last week that was sparked by renewed concerns about tariffs and the health of the economy.

Live Updates Live Coverage Updates appear automatically as they are published. Nasdaq up 300 at the Open 9:54 am Despite a ...

Late last week, President Donald Trump sent letters to 17 pharmaceutical companies pressing them to deliver on his May ...

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and ...

As Eli Lilly rolls ahead with a $27 billion investment to prop up four new manufacturing facilities in the U.S, the company ...

Unless you’ve been living on another planet over the past few years, you have heard of and probably know several people that ...

President Trump escalated pressure on the pharmaceutical industry last week by sending letters to 17 major drug companies ...

Telangana Chief Minister A Revanth Reddy inaugurated Eli Lilly’s new technology hub in Hyderabad, marking a significant leap ...

Eli Lilly and Company faces unexpected stock plunge despite strong growth, prompting caution and reflection among investors in the pharmaceutical sector.

Earlier this year, the Centers for Medicare and Medicaid Services scrapped a previous proposal, from the Biden administration ...